Brief: Avecho Biotechnology Says Undertaking A Capital Raise

Avecho Biotechnology

03/04/2023 01:20

April 3 (Reuters) - Avecho Biotechnology Ltd  AVE.AX :
    * UNDERTAKING A CAPITAL RAISE SEEKING APPROXIMATELY A$11
MILLION
    * RAISE TO FUND PIVOTAL PHASE 3 CLINICAL TRIAL DESIGNED TO
TEST
CO'S PROPRIETARY CBD SOFT-GEL CAPSULE
    * CAPITAL RAISING AT AN ISSUE PRICE OF A$0.006 PER SHARE

Source text for Eikon:  ID:nASX6DlzsT 
Further company coverage:  AVE.AX